- Home
- GEVO vs IHRT Comparison
GEVO vs IHRT Comparison
Compare GEVO & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- IHRT
- Stock Information
- Founded
- GEVO 2005
- IHRT 1974
- Country
- GEVO United States
- IHRT United States
- Employees
- GEVO N/A
- IHRT N/A
- Industry
- GEVO Major Chemicals
- IHRT Broadcasting
- Sector
- GEVO Industrials
- IHRT Consumer Discretionary
- Exchange
- GEVO Nasdaq
- IHRT Nasdaq
- Market Cap
- GEVO 285.1M
- IHRT N/A
- IPO Year
- GEVO 2011
- IHRT 2019
- Fundamental
- Price
- GEVO $1.14
- IHRT $1.21
- Analyst Decision
- GEVO Buy
- IHRT Buy
- Analyst Count
- GEVO 2
- IHRT 3
- Target Price
- GEVO $7.58
- IHRT $2.83
- AVG Volume (30 Days)
- GEVO 2.4M
- IHRT 598.4K
- Earning Date
- GEVO 05-13-2025
- IHRT 05-12-2025
- Dividend Yield
- GEVO N/A
- IHRT N/A
- EPS Growth
- GEVO N/A
- IHRT N/A
- EPS
- GEVO N/A
- IHRT N/A
- Revenue
- GEVO $16,915,000.00
- IHRT $3,854,532,000.00
- Revenue This Year
- GEVO $617.82
- IHRT $0.97
- Revenue Next Year
- GEVO $84.22
- IHRT $5.09
- P/E Ratio
- GEVO N/A
- IHRT N/A
- Revenue Growth
- GEVO N/A
- IHRT 2.76
- 52 Week Low
- GEVO $0.48
- IHRT $0.81
- 52 Week High
- GEVO $3.39
- IHRT $2.84
- Technical
- Relative Strength Index (RSI)
- GEVO 49.70
- IHRT 51.94
- Support Level
- GEVO $1.00
- IHRT $1.02
- Resistance Level
- GEVO $1.14
- IHRT $1.09
- Average True Range (ATR)
- GEVO 0.08
- IHRT 0.08
- MACD
- GEVO 0.00
- IHRT 0.04
- Stochastic Oscillator
- GEVO 60.87
- IHRT 86.67
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.